nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alemtuzumab and the value of neurological research
|
The Lancet Neurology, |
|
2014 |
13 |
3 |
p. 233- 1 p. |
artikel |
2 |
A new encephalitis with GABAA receptor antibodies
|
Hirsch, Lawrence J |
|
2014 |
13 |
3 |
p. 239-240 2 p. |
artikel |
3 |
Cognitive and neurological aspects of sex chromosome aneuploidies
|
Hong, David S |
|
2014 |
13 |
3 |
p. 306-318 13 p. |
artikel |
4 |
Corrections
|
|
|
2014 |
13 |
3 |
p. 240- 1 p. |
artikel |
5 |
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
|
Leist, Thomas P |
|
2014 |
13 |
3 |
p. 257-267 11 p. |
artikel |
6 |
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial
|
Low, Phillip A |
|
2014 |
13 |
3 |
p. 268-275 8 p. |
artikel |
7 |
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
|
Petit-Pedrol, Mar |
|
2014 |
13 |
3 |
p. 276-286 11 p. |
artikel |
8 |
Indian film on epilepsy busts myths
|
Sharma, Dinesh C |
|
2014 |
13 |
3 |
p. 245- 1 p. |
artikel |
9 |
Mood and behavioural effects of subthalamic stimulation in Parkinson's disease
|
Castrioto, Anna |
|
2014 |
13 |
3 |
p. 287-305 19 p. |
artikel |
10 |
Neurobehavioural effects of developmental toxicity
|
Grandjean, Philippe |
|
2014 |
13 |
3 |
p. 330-338 9 p. |
artikel |
11 |
New evidence for teriflunomide in multiple sclerosis
|
Kieseier, Bernd C |
|
2014 |
13 |
3 |
p. 234-235 2 p. |
artikel |
12 |
News in brief
|
|
|
2014 |
13 |
3 |
p. 246- 1 p. |
artikel |
13 |
New treatments for multiple sclerosis: at what long-term risk?
|
Cameron, Michelle H |
|
2014 |
13 |
3 |
p. 235-237 3 p. |
artikel |
14 |
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Confavreux, Christian |
|
2014 |
13 |
3 |
p. 247-256 10 p. |
artikel |
15 |
Paul Krack: deeper brain stimulation
|
Holmes, David |
|
2014 |
13 |
3 |
p. 243- 1 p. |
artikel |
16 |
Plagues and pesticides
|
Goodrick, Steven |
|
2014 |
13 |
3 |
p. 244- 1 p. |
artikel |
17 |
Rifampicin for multiple system atrophy
|
Wenning, Gregor K |
|
2014 |
13 |
3 |
p. 237-239 3 p. |
artikel |
18 |
Should your patient be doing yoga?
|
Burton, Adrian |
|
2014 |
13 |
3 |
p. 241-242 2 p. |
artikel |
19 |
Targeting the β secretase BACE1 for Alzheimer's disease therapy
|
Yan, Riqiang |
|
2014 |
13 |
3 |
p. 319-329 11 p. |
artikel |
20 |
Thomas Leist
|
|
|
2014 |
13 |
3 |
p. 244- 1 p. |
artikel |